The Gene Transfer Vehicle core will synthesize, purify and supply sterile reagents for nucleic acid transfection to researchers involved with gene therapy at the University of California/San Francisco. The reagents will include cationic lipids, peptides, DNA binding molecules and polymers that have been described in the literature or proposed by participants in the Center. The core will be responsible for the structural identification and chemical analysis of novel vehicles. The core will also advise individual investigators on gene delivery vehicles that are most appropriate for their particular application. At the request of and with specialized components provided by the participants, the core will create reagents that might include antibodies, hormones or other cell surface targeting reagents in combination with lipidic or polymeric transfection reagents. In addition, the core will characterize the diameter and charge of transfecting complexes created by investigators in the Center. Finally, the core will advise individual investigators in the delivery of their specific polynucleotide complexes by aerosolization into rodents. The mission of the core is to provide to investigators synthetic gene delivery vehicles capable of high levels of transfection both in vitro and in vivo and to provide the synthetic capability for investigators who suggest improved molecules or compositions for use as gene delivery vehicles.

Project Start
Project End
Budget Start
Budget End
Support Year
4
Fiscal Year
1996
Total Cost
Indirect Cost
Lalwani, Anil K; Han, Jay J; Castelein, Caley M et al. (2002) In vitro and in vivo assessment of the ability of adeno-associated virus-brain-derived neurotrophic factor to enhance spiral ganglion cell survival following ototoxic insult. Laryngoscope 112:1325-34
Hawgood, Samuel; Ochs, Matthias; Jung, Anja et al. (2002) Sequential targeted deficiency of SP-A and -D leads to progressive alveolar lipoproteinosis and emphysema. Am J Physiol Lung Cell Mol Physiol 283:L1002-10
Xu, Z; Jablons, D M; Gruenert, D C (2001) Expression sequence tag-specific full-length cDNA cloning: actin cDNAs. Gene 263:265-72
Gum Jr, J R; Hicks, J W; Gillespie, A M et al. (2001) Mouse intestinal goblet cells expressing SV40 T antigen directed by the MUC2 mucin gene promoter undergo apoptosis upon migration to the villi. Cancer Res 61:3472-9
Colosimo, A; Goncz, K K; Novelli, G et al. (2001) Targeted correction of a defective selectable marker gene in human epithelial cells by small DNA fragments. Mol Ther 3:178-85
Goncz, K K; Colosimo, A; Dallapiccola, B et al. (2001) Expression of DeltaF508 CFTR in normal mouse lung after site-specific modification of CFTR sequences by SFHR. Gene Ther 8:961-5
Colosimo, A; Goncz, K K; Holmes, A R et al. (2000) Transfer and expression of foreign genes in mammalian cells. Biotechniques 29:314-8, 320-2, 324 passim
Camargo, F D; Huey-Louie, D A; Finn, A V et al. (2000) Germline incorporation of a replication-defective adenoviral vector in mice does not alter immune responses to adenoviral vectors. Mol Ther 2:496-504
Laan, M; Cui, Z H; Hoshino, H et al. (1999) Neutrophil recruitment by human IL-17 via C-X-C chemokine release in the airways. J Immunol 162:2347-52
Xu, Y; Hui, S W; Frederik, P et al. (1999) Physicochemical characterization and purification of cationic lipoplexes. Biophys J 77:341-53

Showing the most recent 10 out of 59 publications